Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
Talal El ZarifAmin H NassarElio AdibBailey G FitzgeraldJiaming HuangTarek H MouhieddinePaul G RubinsteinTaylor NonatoRana R McKayMingjia LiArjun MittraDwight H OwenRobert A BaiocchiMichael LorentsenChristopher DittusNazli DizmanAdewunmi FalohunNoha Abdel-WahabAdi DiabAnand BankapurAlexandra ReedChul KimAakriti AroraNeil J ShahEdward El-AmElie KozailyWassim AbdallahAhmad Al-HaderBatool Abu GhazalAnwaar SaeedClaire DrolenMelissa G LechnerAlexandra DrakakiJavier BaenaCaroline A NebhanTarek HaykalMichael A MorseAlessio CortelliniDavid James PinatoAlessia Dalla PriaEvan T HallVeli BakalovNathan BaharyAarthi RajkumarAnkit ManglaVishal ShahParminder SinghFrank Aboubakar NanaNerea Lopetegui LiaDanai DimaRyan W DobbsPauline FunchainRabia SaleemRachel G WoodfordGeorgina V LongAlexander M MenziesCarlo GenovaGiulia BarlettaSonam PuriVaia FlorouDame IdossaMaristella SaponaraPaola QueiroloGiuseppe LambertiAlfredo AddeoMelissa BersanelliDory FreemanWanling XieErin G ReidElizabeth Yu ChiaoElad SharonDouglas B JohnsonRamya RamaswamiMark BowerBrinda EmuThomas U MarronToni K ChoueiriLindsey R BadenKathryn LurainGuru P SonpavdeAbdul Rafeh NaqashPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Among PWH, ICIs demonstrated differential activity across cancer types with no excess toxicity. Safety and activity of ICIs were similar between matched cohorts of PWH and PWOH with mNSCLC.